on Sunday said it has commenced test rides of its 4680 Bharat Cell vehicles at the company’s flagship stores across India. The S1 Pro+ (5.2 kWh) is the first product to be powered by the company’s indigenously manufactured 4680 Bharat Cell battery pack. It delivers more range, better performance, and enhanced safety.
Maruti Suzuki India is recalling 39,506 units of Grand Vitara to replace a faulty fuel indicator part. The company is recalling the affected lot of the model manufactured from December 9, 2024 to April 29, 2025, according to a regulatory filing. It is suspected that the fuel level indicator and warning light in the speedometer assembly in some of these vehicles may not accurately reflect the fuel status as intended, it said.
Lupin has announced that the United States Food and Drug Administration (US FDA) has completed a product-specific Pre-Approval Inspection at its Unit-1 oral solid dosage manufacturing facility in Nagpur. The inspection was carried out from November 10 to November 14, 2025, and concluded with zero 483 observations.
Alembic Pharmaceuticals Limited has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Diltiazem Hydrochloride Tablets USP, 30 mg, 60 mg, 90 mg, and 120 mg. The approved ANDA is therapeutically equivalent to the reference listed drug (RLD), Cardizem Tablets, 30 mg, 60 mg, 90 mg, and 120 mg, of Bausch Health US, LLC. Diltiazem hydrochloride tablets are indicated for the management of chronic stable angina and angina due to coronary artery spasm. Refer to label for a detailed indication.